Have you read enough about vitamin C yet? I hope not, because here’s another post. This one will help me understand a recently published paper that shows a Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. To repeat myself: I do have a KRAS-mutated cancer. This research is potentially very relevant to me. What I don’t have is a fasting-mimicking diet. I’ll get to that at the very end. But first, the paper.
As the paper is about five years more recent than the one I discussed yesterday, it takes those results for granted. KRAS-mutated cancers don’t like high doses of vitamin C, which multiplies the oxidative stress that cancer cells have to deal with as a result of their fast proliferation. Going beyond the earlier research, the paper envisions what might potentiate the action of vitamin C. Fasting seems a good candidate as it also leads to increased oxidative stress in cancer cells.
The paper studies the same cell lines as the one I discussed yesterday, cell lines that carry my KRAS mutation, and shows that vitamin C kills those cells. More cells die if they are grown in conditions that mimic starvation. Vitamin C and fasting have a comparable individual effect on cancer cells. The effect depends on oxidative damage and is stronger when both treatments are combined. Add traditional chemotherapy to the equation and you get a triple whammy that cancer cells have a hard time surviving.
These are exciting results that I need to discuss with my oncologist, but words of warning are in order. It’s a long way from a laboratory bench to a hospital bedside. The mice that were used in this study received four grams of vitamin C per kilogram body weight twice a day. At 62 kg, I would need to handle nearly half a kilogram of vitamin C per day, every day. This sounds impossible but might simply be a reflection of the differences between men and mice. Mice easily lose a quarter of their weight when they’re starved for a few days. I lose a couple of kilograms, something like three to four per cent. I need to find out the doses that were used in the few clinical trials that have taken place.
There’s a couple more rather obscure observations in the paper with no bearing on a possible therapeutic approach. I’ll list them here mostly to have a reference later.
- Cancer cells try to keep iron levels down. Otherwise oxidative stress risks running out of control. Vitamin C and fasting both help keep a lid on the levels of ferritin, a protein that sequesters iron. These double negatives are common in biochemistry. What it means is that both vitamin C and fasting (indirectly) cause iron levels to increase and, collaterally, oxidative stress. Incidentally, low ferritin levels are correlated with increased survival of patients with KRAS mutated tumors according to the Cancer Genome Atlas Database.
- There’s one example where vitamin C and fasting have opposite effects. The enzyme heme oxygenase 1 increases ferritin levels. Somewhat confusingly, vitamin C promotes the expression of this enzyme. This leads to lower iron levels and less oxidative stress. To exploit this, tumors often respond to chemotherapy by upregulating heme oxygenase 1 levels. Fasting, in contrast, drives the levels of heme oxygenase 1 down. The cells suffer more damage from oxidative stress. Fewer of them survive.
From these data you could expect fasting to have a stronger effect on cancer cells than vitamin C, but that’s not necessarily the case according to the paper. You might not think so after reading all this, but biochemistry is relatively straightforward. Biology, in contrast, is much more complicated. In living organisms, one plus one is never two.
What is it about the fasting-mimicking diet (FMD for short) that was used in the paper? It is a way of eating that’s supposed to be easier on the body than total fasting but has much of the same beneficial effects. FMD can slow tumor growth and make cancer cells respond better to chemotherapy. This is exactly what is claimed for periodic fasting. I have a number of papers on my hard drive that discuss the details of FMD. There will be another vaguely scientific post before too long. I have to admit it, I rather enjoy being a biochemist at the moment.